Moscvin, Maria http://orcid.org/0000-0002-0964-0237
Liacos, Christine Ivy
Chen, Tianzeng
Theodorakakou, Foteini
Fotiou, Despina http://orcid.org/0000-0002-0618-8900
Hossain, Shahrier
Rowell, Sean
Leblebjian, Houry
Regan, Eileen
Czarnecki, Peter
Bagnoli, Filippo
Bolli, Niccolo’
Richardson, Paul http://orcid.org/0000-0002-7426-8865
Rennke, Helmut G.
Dimopoulos, Meletios A. http://orcid.org/0000-0001-8990-3254
Kastritis, Efstathios
Bianchi, Giada http://orcid.org/0000-0003-3673-0104
Funding for this research was provided by:
Amyloidosis Foundation (Donald C. Brockman Memorial Research Grant)
Article History
Received: 13 September 2022
Revised: 9 February 2023
Accepted: 15 February 2023
First Online: 27 February 2023
Competing interests
: Giada Bianchi: Advisory board participation (with personal payment): Pfizer, Karyopharm; Maria Moscvin, Christine Ivy Liacos: nothing to disclose. Niccolò Bolli: advisory board participation: Janssen, GSK; honoraria for lectures: GSK, Janssen, Amgen, Takeda. Efstathios Kastritis: Honoraria from Amgen, Janssen, GSK, Pfizer, Takeda and Research Support form Janssen and Amgen. Meletios A. Dimopoulos: honoraria from participation in Advisory Boards from Amgen, BMS, Janssen, Takeda, Beigene. Helmut G. Rennke: Wolters Kluwer Author of Textbook for students, Ionis Pharmaceutical-Consultant Pathologist on IgA nephropathy. Paul Richardson: Consultancy for Oncopeptides, Celgene/BMS, Karyopharm, Sanofi, Secura Bio, GSK, and research funding for Oncopeptides, Celgene/BMS, Karyopharm, Takeda.